In the News

Read, discover, share

In the News

Mar 28

The Orthbiologic Institute TOBI Faculty present new research that shows Platelet Rich Plasma PRP effective for Knee Osteoarthritis with 2 year follow up

TOBI (The Orthobiologic Institute) Faculty & colleagues Alberto Gobbi MD, Georgios Karnatzikos MD from Milan, Italy presented new research at the world’s largest gathering of Orthopaedic Surgeons in Chicago, Illinois last week, the AAOS (American Academy of Orthopaedic Surgery). This study shows PRP Platelet Rich Plasma effective for Knee Osteoarthritis with 2 year follow up. PRP intra-articular knee injections are effective both in operated and non-operated arthritic knees and can act as a preventive agent of Osteoarthritis, by diminishing pain...

Mar 25

TOBI (The Orthobiologic Institute) Faculty Present Large Randomized Trial at AAOS (American Academy of Orthopaedic Surgery) Annual Meeting that Confirms Value of Platelet Rich Plasma for Tennis Elbow Patients

TOBI Faculty, Dr. Allan K. Mishra MD, Steven Sampson DO, and David C. Karli MD, MBA participated in the largest study done to date using PRP. The study was a randomized, double-blind, multi-center controlled trial of 230 patients. Patients received needling of their elbow tendons with and without PRP. At 24 weeks the PRP patients reports a 71.5% improvement in their pain compared to 56.1 in the control group. (P = 0.027) Patients treated with PRP also had less elbow...

Mar 8

Breakthrough Treatment: PRP Therapy Education

New breakthroughs in orthopedic treatment options focus on treating the root of the issue, rather than only addressing symptoms. PRP, or platelet-rich plasma, therapy is one such treatment, harnessing the power of the body’s healing cascade to repair and regenerate damaged tissue. Rather than using a synthetic analgesic or anti-inflammatory medication, PRP utilizes the growth factors and proteins found in one’s own plasma. These cells are injected into lesions or areas of damage to speed the repair process. Educating doctors...